A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?

• Main Authors: Stephane Tshitenge (Author), Gboyega A. Ogunbanjo (Author), Andre Citeya (Author)
• Formato: Livro
• Publicado em: AOSIS, 2018-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: The World Health Organization aims to reduce tuberculosis (TB) mortality rate from 15% in 2015 to 6.5% by 2025. Aim: This study determined the profile of TB and human immunodeficiency virus (HIV) co-infected patients who died in Mahalapye District, Botswana, while on anti-TB medication a...